An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the delivery schedule.
The meeting is the second federal vaccine panel meeting Trump administration officials have canceled or postponed since RFK Jr. took over HHS.
Influenza infections are outpacing COVID-19 cases for the first time since the pandemic. Here are the best ways to stay healthy.
Two long-planned vaccine meetings — one at the US Centers for Disease Control and another at the US Food and Drug Administration — have now been disrupted under the watch of US Health and Human Services Secretary Robert F.
Lab tests suggest a strain of the flu virus circulating this season may not be "well-recognized" by the flu vaccine.
The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss influenza vaccine strains. The meeting was scheduled for March 13.
The influenza vaccine for the 2024/2025 season provided moderate protection against influenza A and strong protection against influenza B, according to an assessment of interim influenza vaccine effectiveness just published in Eurosurveillance.
Aug. 15, 2024 — A unique influenza vaccine candidate that's inhaled appears safe and could bolster protection against seasonal and pandemic influenza for people vulnerable to severe disease when ...
“Findings in this report show that vaccination with the 2024–2025 influenza vaccine reduced the likelihood of medically attended influenza and support CDC’s recommendation that all persons aged ≥6 months be vaccinated against influenza,” concluded the MMWR authors of the influenza VE report.
Marty Makary, Trump’s pick for FDA commissioner, testified before the Senate health committee Thursday.
Cornell researchers have developed a stable, multi-target vaccine offering long-lasting protection against COVID-19 and influenza, with promising results in mice. Cornell University researchers have developed a new vaccine platform designed to offer stronger,